Alzamend Neuro (ALZN)
(Delayed Data from NSDQ)
$2.18 USD
-0.15 (-6.44%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $2.14 -0.04 (-1.83%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Alzamend Neuro, Inc. has a market cap of $7.32M, which represents its share price of $2.33 multiplied by its outstanding shares number of 3.14M. As a small-cap company, ALZN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ALZN 2.18 -0.15(-6.44%)
Will ALZN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ALZN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALZN
Alzamend Neuro (ALZN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?
ALZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ALZN
ALZN forms 20 Day Moving Average Resistance on October 10
Fell Below 20 Day Moving Average appears for ALZN after 7.91% move
Is ALZN gaining bullish strength? 20 Day Moving Average Support shows up after rising 1.61%
Alzamend Neuro Issues New Common Stock Shares
The technical outlook for ALZN is unchanged after it falls 2.73% on October 7